MindWalk Deployed OpenFold3 on Vultr Cloud

The Austin-based company utilized AMD hardware to accelerate biological discovery workflows.

Updated on Sept. 21, 2026 in Quantum Computing

Isometric editorial illustration of a modular metallic server chassis with sharp architectural forms, representing high-performance biological discovery infrastructure.
MindWalk has integrated its OpenFold3 protein prediction model into the Vultr Kubernetes Engine, utilizing AMD hardware to accelerate biological research. AI Illustration. Upload story photo >

Live Poll

Do you trust that AI-driven drug discovery will make medical treatments more affordable for patients?

MindWalk has deployed its OpenFold3 structure prediction model on the Vultr Kubernetes Engine. This integration uses AMD Inference Microservices to run complex biological discovery workflows.

Why it matters

The deployment serves as an independent validation of AMD Inference Microservices in a life-sciences setting. It aims to significantly reduce the timeline between initial engagement and actionable results for enterprise partners.

The production-grade environment utilizes AMD Instinct MI325X GPUs and AMD Inference Microservices. It evaluates complex biological patterns, including 660 million unique structures and 25 billion relationships within its HYFT representation system.

The players

MindWalk

An Austin-based technology company focused on biological discovery workflows.

Vultr

A cloud computing platform provider that operates the Vultr Kubernetes Engine.

AMD

A multinational semiconductor company that develops the Instinct MI325X GPUs used for high-performance computing.

The details

MindWalk ran its discovery workflows directly within the Vultr Kubernetes Engine, achieving a production-ready environment in just minutes. The system is designed to handle diverse molecular data including protein, RNA, DNA, and ligand interactions.

Timeline

  1. ReefIQ launched in June 2026.

  2. MindWalk announced the deployment results on September 21, 2026.

The Tech Race

This integration follows the deployment of the OpenFold3 structure prediction model, marking a shift toward optimizing complex biological research for scalable cloud infrastructure. It highlights the competition between cloud providers to offer specialized, low-latency acceleration for the life-sciences sector.

For enterprise clients in life sciences, this deployment promises significantly faster access to predictive modeling results. The move toward optimized cloud inference suggests that research-heavy industries will see reduced waiting times for complex biological data analysis.

The takeaway

The successful integration of specialized biological models on cloud hardware signals a growing trend in biotech efficiency. Companies aiming for rapid discovery are increasingly leveraging infrastructure-as-a-service providers to shorten their research and development cycles.

Further reading

Learn more about the latest innovations in high-performance Quantum Computing.

More information

Read the full MindWalk and Vultr case study for additional technical specifications.

Live Poll

Do you trust that AI-driven drug discovery will make medical treatments more affordable for patients?